Studying at the University of Verona

Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.

Study Plan

A.A. 2024/2025 A.A. 2023/2024

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Laurea magistrale in Biology for Translational Research and Precision Medicine - Enrollment from 2025/2026

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.

A Basic activities
B Characterizing activities
C Related or complementary activities
D Activities to be chosen by the student
E Final examination
F Other training activities
S Placements in companies, public or private institutions and professional associations

Terapia cellulare e genica - Terapia genica (2023/2024)

Teaching code

4S011586

Credits

6

Coordinator

Not yet assigned

Language

English en

Scientific Disciplinary Sector (SSD)

BIO/11 - MOLECULAR BIOLOGY

Courses Single

Not Authorized

MoodleMoodle Seminars 0

To show the organization of the course that includes this module, follow this link:  Course organization

The teaching is organized as follows:

Teoria

Credits

5

Period

2 SEMESTRE LM-6

Academic staff

Alessandra Ruggiero

Lessons timetable
Laboratorio [TURNO 1]

Credits

1

Period

2 SEMESTRE LM-6

Academic staff

Alessandra Ruggiero

Lessons timetable
Laboratorio [TURNO 2]

Credits

1

Period

2 SEMESTRE LM-6

Academic staff

Alessandra Ruggiero

Lessons timetable

Program

Theoretical part
• Introduction to gene therapy
• Non viral vectors, siRNA and miRNA, peptide vectors
• Gene editing: ZFN, TALEN, Crispr / Cas9
• Viral vectors, generality
• Adenovirus (AV)
• Adeno-associated virus (AAV)
• Herpes and poxvirus vectors
• Retroviral and lentiviral vectors
• Clinical trials: hematologic, metabolic, neurodegenerative, neuromuscular and dystrophies, cystic fibrosis
• Antitumor Gene Therapy, Oncolytic Viruses

Practical part (laboratory)
• Retro and lenti viral vectors carrying specific genes of interest
• Crispr / Cas9

Didactic methods

in presence on zoom

Learning assessment procedures

oral exam

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE

Evaluation criteria

Group presentation on the laboratory experience during which the knowledge acquired during the course will also be verified through 2 questions for each candidate in the group. grade 25-31 for students who answered the two questions correctly and presented the laboratory work exhaustively grade 20-24 for students who answered the two questions partially (or just one question completely) and presented the laboratory work laboratory in a fairly exhaustive manner, grade 18-19 for students who responded poorly to the two questions (or partially to only one question) and presented the laboratory work in a poorly exhaustive manner, grade 0-17 for students who did not answer the two questions ( or partially to a single question) and presented the laboratory work in an insufficiently exhaustive manner

Exam language

English